Proton pump inhibitor use is associated with a reduced risk of infection with intestinal protozoa
Wilderness & Environmental Medicine Sep 15, 2017
Sheele JM - An analysis was performed to ascertain if proton pump inhibitors (PPIs) use was correlated with a reduced risk of having intestinal parasites. Compared with those not taking a PPI, patients taking a PPI were statistically less prone to have intestinal protozoa reported on stool ova and parasite (O & P) examination.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
